Cutaneous leishmaniasis responds to daylight-activated photodynamic therapy: Proof of concept for a novel self-administered therapeutic modality

British Journal of Dermatology

Volumn 172, Issue 5, 2015, Pages 1364-1370

  Enk, C D ^a   Nasereddin, A ^b   Alper, R ^a   Dan Goor, M ^b   Jaffe, C L ^b   Wulf, H C ^c  

^a HEBREW UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; SUNSCREEN;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOTHERAPY; DAYLIGHT ACTIVATED PHOTODYNAMIC THERAPY; DIAGNOSTIC PROCEDURE; FEMALE; HOME CARE; HOSPITAL; HUMAN; LEISHMANIA MAJOR; LEISHMANIA TROPICA; MALE; OPEN STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SELF ADMINISTERED TREATMENT MODALITY; SKIN LEISHMANIASIS; TREATMENT RESPONSE; ADOLESCENT; CLINICAL PROTOCOL; DRUG SELF ADMINISTRATION; LEISHMANIASIS, CUTANEOUS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; FEMALE; HELIOTHERAPY; HUMANS; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; SELF ADMINISTRATION; YOUNG ADULT;

EID: 84929095155     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13490     Document Type: Article

References (23)

1. Anis E, Leventhal A, Elkana Y, et al,. Cutaneous leishmaniasis in Israel in the era of changing environment. Public Health Rev 2001; 29: 37-47.
2. Shani-Adir A, Kamil S, Rozenmann D, et al,. Leishmania tropica in northern Israel-a clinical overview of an emerging focus. J Am Acad Dermatol 2005; 53: 810-15.
3. Singer SR, Abramson N, Shoob H, et al,. Ecoepidemiology of cutaneous leishmaniasis outbreak, Israel. Emerg Infect Dis 2008; 14: 1424-6.
4. Herwaldt BL,. Leishmaniasis. Lancet 1999; 354: 1191-9.
5. González U, Pinart M, Reveiz L, Alvar J,. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev 2008: CD005067.
6. Enk CD, Fritsch C, Jonas F, et al,. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol 2003; 139: 432-4.
7. van der Snoek EM, Robinson DJ, van Hellemond JJ, Neumann HA,. A review of photodynamic therapy in cutaneous leishmaniasis. J Eur Acad Dermatol Venereol 2008; 22: 918-22.
8. Wiegell SR, Haedersdal M, Philipsen PA, et al,. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 2008; 158: 740-6.
9. Schonian G, Nasereddin A, Dinse N, et al,. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 2003; 47: 349-58.
10. Babilas P, Schreml S, Landthaler M, Szeimies RM,. Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed 2010; 26: 118-32.
11. Wilson BC, Patterson MS, Lilge L,. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci 1997; 12: 182-99.
12. Wiegell SR, Wulf HC, Szeimies RM, et al,. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 673-9.
13. Levi A, Wulf HC, Enk CD,. Two cases of actinic cheilitis responsive to daylight-activated photodynamic therapy (DA-PDT). Photodermatol Photoimmunol Photomed 2013; 29: 268-71.
14. Asilian A, Davami M,. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol 2006; 31: 634-7.
15. Sohl S, Kauer F, Paasch U, Simon JC,. Photodynamic treatment of cutaneous leishmaniasis. J Dtsch Dermatol Ges 2007; 5: 128-30.
16. Mosleh IM, Geith E, Natsheh L, et al,. Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis. J Am Acad Dermatol 2008; 58: 617-24.
17. Wiegell SR, Fabricius S, Heydenreich J, et al,. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations. Br J Dermatol 2013; 168: 186-91.
18. Wiegell SR, Fabricius S, Gniadecka M, et al,. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Br J Dermatol 2012; 166: 1327-32.
19. Akilov OE, Yousaf W, Lukjan SX, et al,. Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis. Lasers Surg Med 2009; 41: 358-65.
20. Song D, Lindoso JA, Oyafuso LK, et al,. Photodynamic therapy using methylene blue to treat cutaneous leishmaniasis. Photomed Laser Surg 2011; 29: 711-15.
21. Taylor VM, Cedeno DL, Munoz DL, et al,. In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis. Antimicrob Agents Chemother 2011; 55: 4755-64.
22. Barbosa AF, Sangiorgi BB, Galdino SL, et al,. Photodynamic antimicrobial chemotherapy (PACT) using phenothiazine derivatives as photosensitizers against Leishmania braziliensis. Lasers Surg Med 2012; 44: 850-5.
23. Montanari J, Maidana C, Esteva MI, et al,. Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark. J Control Release 2010; 147: 368-76.